The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Cyberonics to Participate in 2011 UBS Global Life Sciences Conference

Wednesday, September 07, 2011

Cyberonics to Participate in 2011 UBS Global Life Sciences Conference09:00 EDT Wednesday, September 07, 2011HOUSTON, Sept. 7, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in epilepsy management, today announced it will participate in the 2011 UBS Global Life Sciences Conference on Wednesday, September 21, 2011, in New York.Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference 10:00 AM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on September 21, 2011.About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.Contact informationGreg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262Fax:  (281) 218-9332ir@cyberonics.comSOURCE Cyberonics, Inc.